


























































Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
A comprehensive overview of hemodynamic monitoring, including its principles, techniques, and clinical applications. It delves into the assessment and management of heart failure, covering its causes, risk factors, compensatory mechanisms, and nursing interventions. The document also explores various cardiac dysrhythmias, their ecg characteristics, and treatment strategies. It includes numerous questions and answers to reinforce learning and promote critical thinking.
Typology: Lecture notes
1 / 66
This page cannot be seen from the preview
Don't miss anything!
Disseminated Intravascular Coagulation DIC Definition : A serious bleeding and clotting disorder caused by abnormally initiated and accelerated clotting, leading to depletion of clotting factors and platelets, which can result in uncontrollable bleeding. Cause : DIC is not a primary disease but occurs secondary to another condition (e.g., cancer, infection, trauma). The underlying cause must be treated to resolve DIC. Pathophysiology: Clotting Cascade : DIC is triggered by an underlying condition causing overactivation of the clotting cascade. Thrombosis & Bleeding : Excessive clot formation occurs due to intravascular thrombin, leading to thrombosis and depletion of clotting factors, followed by profuse bleeding. Fibrinolysis : The fibrinolytic system is activated, breaking down clots and creating fibrin split products (FSPs), which inhibit further clotting. Risk Factors: Shock o Cardiogenic o Anaphylaxis o Hemorrhagic Vascular Disorders o Aortic Aneurism Clinical Manifestations:
a. Blood Products : Platelets, cryoprecipitate, and fresh frozen plasma (FFP) for patients with significant bleeding. b. Cryoprecipitate : Replaces fibrinogen and factor VIII. c. FFP : Replaces clotting factors except platelets.
Measurements : Systolic, diastolic, and mean arterial pressure (MAP). The system must be zeroed at the phlebostatic axis for accurate measurements. Dynamic Response Testing : Ensures the monitoring system is optimally damped and responsive. Complications : Hemorrhage, infection, thrombus formation, neurovascular impairment, and potential loss of limb. Risks of dislodgment and catheter infection can be minimized by using proper connections and sterile technique.
2. Arterial Pressure-Based Cardiac Output (APCO) Function : Measures continuous cardiac output (CO) by analyzing the arterial pulse pressure. Indications : Monitoring a patient’s ability to increase stroke volume (SV) in response to fluid administration, especially in critically ill patients. Measurements : Continuous CO and SV, using demographic data (gender, age, height, weight), arterial pulse pressure, and heart rate (HR). Technology : A sensor attached to an arterial line provides continuous updates of CO and stroke volume variation (SVV), which helps predict fluid responsiveness. 3. Pulmonary Artery (PA) Pressure Monitoring Indications : PA pressure monitoring is useful for managing heart and lung conditions such as heart failure, shock, and pulmonary hypertension. Catheter : A PA catheter (e.g., Swan-Ganz) measures PA pressure and PA wedge pressure (PAWP), reflecting left atrial pressure and left ventricular end-diastolic pressure. Procedure : A multi-lumen catheter is inserted, and the pressure waveforms are observed to guide placement. The catheter tip is positioned in the PA, and a balloon is inflated to obtain PAWP. Measurements : Right atrial pressure (central venous pressure), right ventricular pressure, and mixed venous oxygen saturation (SvO2). Thermodilution can be used to measure CO. Complications : Dysrhythmias, infection, and potential catheter misplacement. PA pressure monitoring use has decreased due to the invasive nature and associated risks, with less invasive methods becoming more prevalent. 4. Complications of Invasive Pressure Monitoring Hemorrhage : Often occurs if the catheter becomes dislodged. To prevent this, ensure secure connections, activate alarms, and monitor the arterial waveform. Infection : Proper site care, routine inspection, and timely replacement of equipment are essential to minimize infection risks. Thrombus Formation : Continuous slow flushing (1–3 mL/hr) with a pressure bag inflated to 300 mm Hg helps prevent clots. Neurovascular Impairment : Regular assessment of the insertion site and extremities (e.g., temperature, color, capillary refill) can detect early signs of compromised blood flow. High- and Low-Pressure Alarms : Ensure alarms are set based on the patient's specific status, as conditions such as heart failure (HF) or volume depletion can alter pressure readings. In HF, the systolic upstroke may be slower, while in volume depletion, systolic pressure drops during inspiration. For patient safety, Luer-Lok connections should be used, and continuous monitoring of arterial waveforms is essential. Infection Control : Inspect the insertion site for signs of infection or inflammation. Replace pressure tubing, flush bags, and transducers every 96 hours (or per institutional policy). Notify healthcare providers (HCP) if infection is suspected and replace equipment as necessary. Complications of Catheter Insertion : Thrombus formation, emboli, or arterial spasm can lead to circulatory impairment. Assess the neurovascular status of the distal limb hourly. Perform the Allen test before radial artery catheterization to confirm adequate ulnar circulation.
Flush System Management : Maintain line patency and prevent thrombus formation by ensuring the flush system delivers a slow continuous flush (1-3 mL/hr). Keep the pressure bag inflated to 300 mm Hg. APCO Monitoring : This minimally invasive technique measures continuous cardiac output (CCO) and stroke volume (SV), integrating arterial waveform data with patient demographics (age, gender, height, weight). APCO also helps evaluate preload responsiveness through stroke volume variation (SVV). Pulmonary Artery Catheters (Swan-Ganz): These are used to assess fluid status and cardiac function by monitoring pulmonary artery pressures, including pulmonary artery diastolic pressure (PADP) and pulmonary artery wedge pressure (PAWP). PA pressures can guide fluid therapy, helping avoid over- or under-resuscitation. PA catheter insertion carries risks (e.g., dysrhythmias, infection), so monitoring the ECG during insertion is critical to detect abnormal heart rhythms. Central Venous Pressure (CVP) Monitoring: CVP reflects right ventricular preload and overall fluid status, measured via a central venous catheter or the proximal port of a pulmonary artery catheter. High CVP indicates fluid overload or right ventricular failure, while low CVP suggests hypovolemia. Nursing Assessment : Evaluate the patient’s general appearance, skin temperature, peripheral pulses, urine output, and mental status to assess hemodynamic status. Continuous observation and correlation of clinical data with hemodynamic values (e.g., ECG, arterial and PA pressures, central venous oxygenation levels) are crucial.
1. Blood Studies & Cardiac Biomarkers: Troponin (cTnT, cTnI) : Specific markers for myocardial infarction (MI). Detected within 4-6 hours of injury, peak at 10-24 hours, and remain detectable for 10-14 days. High-sensitivity assays (hs-cTnT, hs-cTnI) detect events within 1-3 hours. Creatine Kinase-MB (CK-MB) : Rises in 3-6 hours post-MI, peaks in 12-24 hours, and returns to normal within 12-48 hours. Less commonly used now for MI diagnosis. C-Reactive Protein (CRP) : Indicates inflammation and is associated with atherosclerosis. Can predict future cardiac events. Homocysteine (Hcy) : Elevated levels are linked to cardiovascular disease (CVD) and stroke risk. B-Type Natriuretic Peptide (BNP) : Marker for heart failure (HF). Helps distinguish between cardiac and respiratory causes of dyspnea. 2. Serum Lipid Panel: Triglycerides : Elevated levels are linked to coronary artery disease (CAD). Cholesterol : Total cholesterol levels alone do not provide sufficient information about CAD risk. LDLs (bad cholesterol) and HDLs (good cholesterol) are more relevant indicators. High LDL is linked to CAD; high HDL has a protective effect. Lipoprotein (a) [Lp(a)] and Lipoprotein-associated phospholipase A2 (Lp-PLA2) : Indicators of atherosclerosis and increased CAD risk. 3. Electrocardiography (ECG): 12-Lead ECG : Basic heart rhythm assessment for detecting abnormalities like MI. Holter Monitoring : Continuous ECG monitoring for 24-48 hours to assess intermittent arrhythmias. Event Monitor : For patients with less frequent symptoms; records ECG during specific events. Exercise Stress Testing : Evaluates the heart’s response to physical stress to assess CVD.
A. Assess for signs of infection at the insertion site. B. Monitor the patient’s urine output. C. Perform a neurovascular assessment of the limb distal to the catheter insertion site. D. Check for signs of fluid overload. Correct Answer: C. Perform a neurovascular assessment of the limb distal to the catheter insertion site Rationale: One of the major complications of arterial catheterization is neurovascular impairment. Assessing the distal limb for color, temperature, and capillary refill ensures the circulation is intact and prevents ischemic complications. A. Signs of infection are important but neurovascular impairment is more urgent in the acute phase. B. Urine output may reflect overall fluid status but is not directly related to catheter complications. D. Fluid overload is relevant but less immediately critical in this situation. Question 3: The nurse is interpreting a patient's pulmonary artery wedge pressure (PAWP). The patient's PAWP is elevated. Which condition is the nurse most likely to suspect? A. Hypovolemia B. Left ventricular failure C. Pulmonary embolism D. Right-sided heart failure Correct Answer: B. Left ventricular failure Rationale: Pulmonary artery wedge pressure (PAWP) reflects left atrial pressure and left ventricular end-diastolic pressure. An elevated PAWP is a sign of left-sided heart failure or fluid overload. A. Hypovolemia would cause a decreased PAWP. C. Pulmonary embolism does not directly increase PAWP but may increase pulmonary artery pressure. D. Right-sided heart failure affects central venous pressure (CVP), not PAWP. Question 4: A nurse is caring for a patient with an arterial catheter placed for arterial blood pressure (ABP) monitoring. To ensure accurate pressure readings, the nurse should position the transducer at which anatomical location? A. Fifth intercostal space, midclavicular line B. Second intercostal space, midaxillary line C. Fourth intercostal space, midaxillary line D. Xiphoid process Correct Answer: C. Fourth intercostal space, midaxillary line Rationale: The phlebostatic axis is located at the 4th intercostal space, midaxillary line. This is the correct reference point to zero the transducer for accurate pressure readings. A. Fifth intercostal space, midclavicular line is the location for heart auscultation, not hemodynamic monitoring. B. Second intercostal space is incorrect. D. Xiphoid process is irrelevant for this purpose. Question 5: A nurse is caring for a patient with a pulmonary artery catheter in place for hemodynamic monitoring. Which of the following findings is most concerning and requires immediate intervention?
A. Systolic blood pressure of 140 mmHg B. PAWP of 22 mmHg C. Heart rate of 85 bpm D. Central venous pressure (CVP) of 5 mmHg Correct Answer: B. PAWP of 22 mmHg Rationale: A normal PAWP is 6-12 mmHg. A PAWP of 22 mmHg indicates severe fluid overload or left ventricular failure, which requires immediate intervention. A. Systolic blood pressure of 140 mmHg may be elevated but is not immediately concerning. C. Heart rate of 85 bpm is within normal range. D. CVP of 5 mmHg is within the normal range (2-8 mmHg). Question 6: The nurse is assessing a patient with a central venous catheter. Which of the following would indicate a potential infection at the catheter insertion site? A. Localized warmth and erythema around the insertion site B. A MAP of 70 mmHg C. Blood pressure readings higher than baseline D. Increased urine output Correct Answer: A. Localized warmth and erythema around the insertion site Rationale: Signs of infection at the catheter site include localized warmth, erythema, swelling, and purulent drainage. This requires immediate attention to prevent systemic infection. B. A MAP of 70 mmHg is within normal range and doesn’t indicate infection. C. Blood pressure readings may change due to many reasons unrelated to infection. D. Increased urine output is not a sign of infection. Question 7: A critically ill patient is being monitored using arterial pressure-based cardiac output (APCO) monitoring. Which of the following assessments is the nurse likely to use to evaluate fluid responsiveness? A. Central venous pressure (CVP) B. Pulmonary artery pressure (PAP) C. Stroke volume variation (SVV) D. Pulmonary artery wedge pressure (PAWP) Correct Answer: C. Stroke volume variation (SVV) Rationale: Stroke volume variation (SVV) is used in arterial pressure-based cardiac output (APCO) monitoring to evaluate fluid responsiveness, especially in critically ill patients. A. CVP measures right ventricular preload but is less accurate for fluid responsiveness. B. Pulmonary artery pressure (PAP) assesses pulmonary function but does not directly indicate fluid responsiveness. D. PAWP assesses left ventricular preload but SVV is more commonly used in APCO monitoring. Question 8: A nurse is caring for a patient receiving hemodynamic monitoring. The patient’s systemic vascular resistance (SVR) is elevated. Which of the following medications is the nurse most likely to administer to reduce SVR?
Definition: Hypertensive Crisis : SBP > 180 mm Hg and/or DBP > 120 mm Hg. o Hypertensive Emergency : Evidence of target organ damage (e.g., brain, heart, kidneys). Requires immediate treatment and hospitalization. o Hypertensive Urgency : No organ damage. Outpatient management possible. Causes: Primary causes : o Exacerbation of chronic hypertension o Medication non-adherence or withdrawal (e.g., clonidine, beta-blockers) o Drug use (cocaine, amphetamines) o Pheochromocytoma o Head injury, preeclampsia, aortic dissection o MAOIs with tyramine-containing foods Clinical Manifestations: Hypertensive Emergency : Often presents hypertensive encephalopathy. o Symptoms : Severe headache, nausea, vomiting, seizures, confusion, coma, blurry vision, chest pain, dyspnea, nosebleeds, seizures. o End-organ damage signs : Brain : Cerebral edema, seizures, coma Heart : Unstable angina, MI, pulmonary edema Kidneys : Renal insufficiency to renal failure Aortic dissection : Sudden chest/back pain, reduced peripheral pulses o Retinal signs : Exudates, hemorrhages, papilledema Assessment and Monitoring: Vital Signs : Continuous BP, O2 saturation, ECG monitoring. Heart/Lung sounds : Auscultation for abnormalities. Neurologic Checks : Level of consciousness, pupillary reactions, movement of extremities. Renal Function : Measure urine output hourly. Ongoing monitoring : Cardiac, lung, and renal system decompensation. Interventions: Initial Management : o IV Antihypertensive Therapy : For hypertensive emergencies (e.g., sodium nitroprusside, labetalol, nicardipine). o MAP Control : Initial goal: Decrease MAP by no more than 20%-25% or reduce MAP to 110-115 mm Hg. o Caution : Avoid rapid BP reduction to prevent ischemic events (e.g., stroke, MI, renal failure). o Special Cases : Aortic Dissection : SBP < 100-120 mm Hg ASAP. Stroke : May maintain higher BP initially for perfusion. o Titrate Drugs : Based on MAP or SBP. Check BP every 2-3 minutes during initial treatment. o Continuous Monitoring : ECG, urine output, BP. Oxygen Therapy : Administer as per protocol. IV Access : For drug administration and monitoring. Bed Rest : Limit movement to prevent cerebral ischemia and fainting.
Medications: IV Agents (used for emergencies): o Vasodilators : Sodium nitroprusside, nicardipine o Adrenergic Inhibitors : Labetalol, esmolol o CCBs : Clevidipine o Frequent BP Monitoring : 2–3-minute intervals with titration based on response. Oral Medications (used for urgency): o Captopril o Labetalol o Clonidine o Amlodipine Patient Education: Importance of medication adherence. Management of risk factors and ongoing monitoring. Follow-up care to prevent future crises. Complications if Untreated: Hypertensive Emergency mortality rate >79% within a year. Complications : Stroke, MI, renal failure, aortic dissection, pulmonary edema, encephalopathy. QUESTIONS (GPT) Question 1: A patient is admitted with a hypertensive emergency. The nurse notes the patient has blurred vision, a severe headache, and confusion. Which of the following interventions is most important to initiate immediately? A. Administer oral clonidine. B. Begin IV antihypertensive therapy. C. Encourage the patient to rest and remain calm. D. Place the patient in a semi-Fowler’s position. Correct Answer: B. Begin IV antihypertensive therapy. Rationale: In a hypertensive emergency, the priority is to lower the blood pressure to prevent further end-organ damage, and this is done through IV antihypertensive therapy. Oral medications, such as clonidine (choice A), are too slow-acting for a hypertensive emergency, which requires rapid blood pressure control. Encouraging rest (choice C) and positioning (choice D) may be helpful but are not the priority interventions in this situation. Question 2: A patient is admitted with an aortic dissection and a systolic blood pressure (SBP) of 185 mmHg. Which of the following is the priority goal for this patient’s blood pressure management? A. Decrease the SBP to < 150 mmHg within the first hour. B. Maintain the SBP at 140-160 mmHg. C. Decrease the SBP to < 100-120 mmHg as quickly as possible. D. Reduce the mean arterial pressure (MAP) by no more than 25% within the first hour. Correct Answer: C. Decrease the SBP to < 100-120 mmHg as quickly as possible. Rationale: In patients with aortic dissection , rapid reduction of systolic blood pressure is critical to reduce the risk of rupture. The goal is to decrease the SBP to less than 100-120 mmHg as quickly as possible. The other options are incorrect because they suggest less aggressive management, which is not appropriate for aortic dissection, a life-threatening condition. Question 3: The nurse is caring for a patient with a hypertensive urgency. Which of the following is an appropriate intervention for this patient? A. Administer IV nitroprusside. B. Start the patient on oral labetalol. C. Initiate continuous BP monitoring. D. Begin oxygen therapy immediately. Correct Answer: B. Start the patient on oral labetalol. Rationale: In hypertensive urgency , there is no evidence of target organ damage, so the treatment can be managed with oral medications such
Unstable Angina Definition : Caused by the rupture of unstable plaque, exposing thrombogenic surface. Characteristics : o New-onset angina. o Chronic stable angina that increases in frequency, duration, or severity. o Occurs at rest or with minimal exertion. o Pain lasts longer than 10 minutes. Interprofessional and Nursing Care for Chronic Stable Angina Progression Risk : Chronic stable angina can progress to Acute Coronary Syndrome (ACS) or Myocardial Infarction (MI). Any change in angina pattern should be evaluated. Goals of Treatment : o Pain relief. o Immediate and appropriate treatment. o Preservation of heart muscle if MI is suspected. o Effective coping with anxiety. o Participation in rehabilitation. o Reduction of risk factors. Acute Care Protocol for Chest Pain
Drug Therapy Overview Nitrates : First-line for acute angina; monitor for orthostatic hypotension. ACE Inhibitors/ARBs : For patients with EF ≤40%, diabetes, hypertension, or chronic kidney disease. Beta-Blockers : Indicated for relieving angina; monitor for bradycardia and hypotension. Calcium Channel Blockers : For those intolerant to beta-blockers; monitor for peripheral edema and constipation. Lipid-Lowering Agents : Essential for managing cholesterol levels. Sodium Current Inhibitor (Ranolazine) : Used if other treatments are ineffective; does not affect BP/HR. Important Drug Alerts Nitrates : o Store in dark, airtight container. o Sit before taking SL NTG; it should cause a tingling sensation. o Do not combine with erectile dysfunction medications. o Monitor for headaches and orthostatic hypotension. Diagnostic and Intervention Studies for Chest Pain and CAD Initial Assessment Patient History : Detailed health history and physical assessment for new-onset chest pain or changes in chronic stable angina. 12-Lead ECG : Compare with previous ECG to identify changes indicating acute coronary syndrome (ACS). Laboratory Tests : o Cardiac Biomarkers : Determine presence of ACS. o Lipid Profile & CRP : Identify CAD risk factors. Chest X-ray : Assess for heart enlargement, aortic calcifications, and pulmonary congestion. Echocardiogram : Detects resting left ventricular (LV) wall motion abnormalities suggestive of CAD. Stress Testing If ECG and biomarkers are negative: o Exercise Stress Test : May include imaging (echocardiography or nuclear imaging). o Pharmacologic Stress Test : For patients unable to walk (e.g., adenosine or dobutamine). o Imaging : Abnormal if blockages >50% in left main artery or >70% in other vessels. o EBCT or CCTA : Considered if ACS is ruled out and the patient is pain-free. Cardiac Catheterization Gold Standard Test : For increasing angina symptoms. Indications : Positive ECG changes or biomarkers; abnormal stress test. Revascularization Options : o Percutaneous Coronary Intervention (PCI) : Includes balloon angioplasty and stent placement. Stents : Bare metal (BMS) vs. drug-eluting (DES) to prevent restenosis. DAPT : Dual antiplatelet therapy (e.g., aspirin + clopidogrel) post-PCI. Potential Complications of PCI
Ischemic Process Timeline : o Heart muscle cells become hypoxic within 10 seconds of total occlusion. o Viability lasts about 20 minutes without collateral circulation. o Complete necrosis can take 4-6 hours for full thickness of the heart muscle, up to 12 hours if not completely occluded. Metabolic Changes : o Initial anaerobic metabolism leads to lactic acid accumulation. o Restoration of blood flow allows aerobic metabolism to resume. Unstable Angina (UA) Characteristics : o New onset, occurs at rest, or increases in frequency/duration with less effort. o Lasts 10 minutes or more. o ECG may show ischemic changes (ST depression/T wave inversion). Myocardial Infarction (MI) Classification : o STEMI : Caused by an occlusive thrombus. Requires emergency intervention (PCI or thrombolytic therapy) within 90 minutes. o NSTEMI : Caused by a nonocclusive thrombus. No ST elevation; managed with catheterization within 12-72 hours. Thrombolytics are not used. Risk Factors : o Most MIs occur in individuals with preexisting coronary artery disease (CAD). Location of Infarction : o Right Coronary Artery : Supplies inferior/posterior walls. o Left Anterior Descending (LAD) Artery : Supplies anterior wall. o Left Circumflex Artery : Supplies lateral wall. Collateral Circulation : o The degree of collateral circulation influences the severity of the MI. Older patients may have developed collateral circulation, providing better outcomes compared to younger individuals with similar blockages. Diagnostic Considerations Cardiac Biomarkers : Serum levels increase with myocardial damage; crucial for distinguishing NSTEMI from UA. Echocardiogram : May show hypokinesis or akinesis in the affected area, indicating contractility issues. Nursing Implications Immediate Assessment : Compare current ECG with previous ECG if available. Monitoring : Regular assessment of vital signs, ECG changes, and cardiac biomarkers. Patient Education : Importance of seeking immediate medical attention for chest pain. Summary Points for NCLEX Recognize signs and symptoms of ACS and different types of MI. Understand the urgency of STEMI treatment. Differentiate between UA, NSTEMI, and STEMI based on clinical presentation and ECG changes. Be aware of the importance of collateral circulation in MI outcomes.
Diagnostic Studies for Acute Coronary Syndrome (ACS)
Post-Acute Care: Focus on effective coping with anxiety, participation in rehabilitation, and risk reduction. Nutrition Therapy Start NPO (nothing by mouth) until stable; advance to a heart-healthy diet. Implementation of Care in Acute Coronary Syndrome Monitoring and Assessment Vital Signs : Monitor vital signs and pulse oximetry frequently (every hour initially) and continuously in ICU/telemetry settings. ECG Monitoring : Start continuous ECG monitoring and obtain serial 12-lead ECGs. Monitor for dysrhythmias, especially sustained VT and VF. Cardiac Biomarkers : Draw serial cardiac biomarkers to assess heart function. Physical Assessment : Regularly assess for signs of heart failure (HF) such as dyspnea, tachycardia, and peripheral edema. Check input/output and for nasal cannula irritation. Pain Management Medications : Administer nitroglycerin (NTG), morphine, and supplemental oxygen as needed for chest pain. Documentation : Continuously evaluate and document pain relief and the effectiveness of interventions. Patient Education : Educate patients about the importance of ongoing treatment even after pain relief. Treatment Protocols Unstable Angina (UA) and NSTEMI : Use heparin (unfractionated or low molecular weight) to prevent microemboli. Dual antiplatelet therapy (DAPT) with aspirin and ticagrelor is recommended. STEMI Treatment : Initiate reperfusion therapy (emergent PCI preferred) as soon as possible. Use thrombolytics if PCI is unavailable. Rest and Comfort Gradual Activity : Encourage gradual increase in activity; patients may sit in a chair post-event if stable. Comfort Measures : Create a quiet environment and employ relaxation techniques to promote comfort. Phases of Cardiac Rehabilitation
Lifestyle Changes : Discuss risk factors and management strategies, importance of cardiac rehabilitation, and gradual activity resumption. Expectations for Recovery : Offer anticipatory guidance on recovery, work, and lifestyle changes. Physical Activity and Cardiac Rehabilitation